Palonosetron Hydrochloride Injection, Solution
Product Images NDC 0703-4094

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Palonosetron Hydrochloride (NDC 0703-4094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Palonosetron Hydrochloride Structural Formula (Image 1)

Chemical structure of Palonosetron Hydrochloride, showing its molecular framework with a multi-ring system and a piperidine moiety linked to the core structure, along with the hydrochloride (HCl) component.*

FDA Label Image

Table 5 (Image 2)

A data table presenting results from chemotherapy studies comparing complete response rates for Palonosetron Hydrochloride Injection 0.25 mg intravenously versus comparators Ondansetron and Dolasetron. The table includes study categories (Moderately Emetogenic, Highly Emetogenic), treatment groups, sample sizes (N), percentages with complete response, and p-values. A small chart shows the 97.5% confidence intervals for differences in response rates between Palonosetron and comparators.*

FDA Label Image

Table 6 (Image 3)

A data table presenting chemotherapy studies comparing treatment groups for Palonosetron Hydrochloride Injection 0.25 mg intravenously and other intravenous antiemetics. The table lists sample sizes (N), percentage with complete response, and p-values for statistical significance, along with a 97.5% confidence interval graph of difference in complete response rates for Palonosetron Hydrochloride Injection versus comparator treatments.*

FDA Label Image

Table 7 (Image 4)

A data table showing clinical study results comparing the complete response rates of Palonosetron Hydrochloride Injection 0.25 mg intravenously to other treatments in moderately emetogenic chemotherapy. It includes study identification, treatment groups, number of patients, percentage with complete response, p-values, and a 97.5% confidence interval graph for the difference in complete response rates between Palonosetron and comparators.*

FDA Label Image

Carton (Image 5)

Packaging label for Palonosetron Hydrochloride Injection 0.25 mg/5 mL (0.05 mg/mL) intravenous solution. The label indicates a 5 mL single-dose sterile vial and includes storage instructions, manufacturing details (Teva Pharmaceutical Industries Ltd., Israel, and Teva Pharmaceuticals USA), and a barcode. The product is Rx only and the NDC is 0703-4094-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.